{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:51:54Z","timestamp":1743267114321,"version":"3.37.3"},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Colorectal cancer is the third most common type of cancer in both men and women and ranks second as the most common cause of cancer death in the United States. Classic risk factors include tobacco smoking, high alcohol consumption, physical inactivity and excess body weight. A prospective study found that an elevated serum uric acid was associated with higher rates of cancer-associated polyps. Interestingly, other studies found an association between elevated levels of serum uric acid and other types of cancer including colorectal cancer.  Objective: Our study aimed to evaluate whether patients with chronic tophaceous gout had an increased risk of developing colorectal cancer.  Methods: A validated multicenter and research platform database of more than 360 hospitals from 26 different healthcare systems across the United States was utilized to construct this study. Patients aged 18 years and above were included. Individuals who have had a history of familial adenomatous polyposis, a family history of colon cancer, and those diagnosed with inflammatory bowel disease were excluded from the analysis. The risk of developing colon cancer was calculated using a multivariate regression analysis to account for potential confounders.  Results: 80,927,194 individuals were screened in the database and 70,177,200 were selected in the final analysis after accounting for inclusion and exclusion criteria. Type 2 diabetics (28.57%), smokers (10.98%), obese individuals (18.71%), alcoholics (3.13%), and patients who have had a diagnosis of chronic tophaceous gout were more common in the colon cancer group compared to those without the malignancy. Using multivariate regression analysis, risk of colon cancer was calculated for male gender (OR: 1.02; 95%CI: 1.01-1.03), smokers (OR: 1.54; 95%CI: 1.52-1.56), alcoholics (OR: 1.40; 95%CI: 1.37-1.43), obese patients (OR: 1.52; 95%CI: 1.50-1.54), type 2 diabetic individuals (OR: 3.53; 95%CI: 3.50-3.57), and those who have had a diagnosis of chronic tophaceous gout (OR: 1.40; 95%CI: 2.48-3.23).  Conclusion: As expected, patients with colon cancer were found to have a higher prevalence in males, obese, tobacco and alcohol users. We also demonstrated that patients with gout have a significantly higher prevalence of CRC than those who do not before and after adjusting for metabolic risk factors. In fact, uric acid was found to induce production of reactive oxygen species, thus potentially promoting tumorigenesis. It would be interesting to assess the prevalence of colon cancer in patients with gout who have a serum uric acid that is less than 7 mg\/dL. This might promote a tighter control of serum uric acid levels in this population in order to decrease the risk of colon cancer.<\/jats:p>","DOI":"10.1590\/s0004-2803.230302023-43","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:44:32Z","timestamp":1695642272000},"page":"339-344","source":"Crossref","is-referenced-by-count":4,"title":["INCREASED RISK OF COLORECTAL CANCER IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT: A POPULATION-BASED STUDY"],"prefix":"10.1590","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-1443","authenticated-orcid":false,"given":"Antoine","family":"BOUSTANY","sequence":"first","affiliation":[{"name":"Cleveland Clinic Foundation,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-1911","authenticated-orcid":false,"given":"Romy","family":"RAHHAL","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7331-1592","authenticated-orcid":false,"given":"Jad","family":"MITRI","sequence":"additional","affiliation":[{"name":"St. Elizabeth\u2019s Medical Center,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5060-3131","authenticated-orcid":false,"given":"Somtochukwu","family":"ONWUZO","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-3043","authenticated-orcid":false,"given":"Hadi Khaled Abou","family":"ZEID","sequence":"additional","affiliation":[{"name":"University of Balamand,  Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-6625","authenticated-orcid":false,"given":"Imad","family":"ASAAD","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: National cancer statistics","volume":"128","author":"Cronin KA","year":"2022","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.med.46.1.371","article-title":"Genetics of colon cancer: impact of inheritance on colon cancer risk","volume":"46","author":"Burt RW","year":"1995","journal-title":"Annu Rev Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4251\/wjgo.v7.i10.204","article-title":"Treatment of colorectal cancer in the elderly","volume":"7","author":"Millan M","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMra2200869","article-title":"Increasing Incidence of Early-Onset Colorectal Cancer","volume":"386","author":"Sinicrope FA","year":"2022","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu Y","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth N","year":"2016","journal-title":"Lancet"},{"key":"ref8","first-page":"Itc1","article-title":"Gout (Heinig, 2006 #7925)","volume":"165","author":"Neogi T","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3892\/mco.2013.204","article-title":"Predicting the occurrence of cancer-associated colorectal polyp using a metabolic risk score","volume":"2","author":"Orannapalai N","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"16677","DOI":"10.1038\/s41598-022-20357-7","article-title":"The relationship between serum uric acid and colorectal cancer: a prospective cohort study","volume":"12","author":"Li W","year":"2022","journal-title":"Scientific reports"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3949\/ccjm.73.12.1059","article-title":"Role of uric acid in hypertension, renal disease, and metabolic syndrome","volume":"73","author":"Heinig M","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"ref12","first-page":"4759","article-title":"Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants","volume":"37","author":"Carini F","year":"2017","journal-title":"Anticancer research"},{"year":"2020","series-title":"The IBM Explorys Platform: liberate your healthcare data","key":"ref13"},{"year":"2023","series-title":"SNOMED CT","key":"ref14"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson SJ","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"ref16","first-page":"1","article-title":"Epidemiology and risk of colorectal cancer in patients with a history of Helicobacter pylori infection: a population-based study","volume":"36","author":"Boustany A","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"ref17","first-page":"6","article-title":"Increased Risk of Central Retinal Vein Occlusion in Patients with Inflammatory Bowel Disease: A Population-Based Study","author":"Boustany A","year":"2022","journal-title":"J Ophtalmol Open Access"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4254\/wjh.v15.i2.265","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study","volume":"15","author":"Onwuzo SS","year":"2023","journal-title":"World J Hepatol"},{"key":"ref19","article-title":"Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study","volume":"15","author":"Onwuzo S","year":"2023","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/jgh.16163","article-title":"Non-alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus","volume":"38","author":"Boustany A","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jgh.16049","article-title":"Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature","volume":"38","author":"Almomani A","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung H","year":"2021","journal-title":"CA Cancer J Clin"},{"year":"2020","series-title":"WSQARS (Web based Injury Statistics Quey and Reporting System)","key":"ref23"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/cancers13092025","article-title":"A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis","volume":"13","author":"Sawicki T","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"152040","DOI":"10.1016\/j.semarthrit.2022.152040","article-title":"Modifiable risk factors and incidence of gout: Estimation of population attributable fraction in the US","volume":"55","author":"Liu K","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1907","article-title":"Epidemiology, risk factors, and lifestyle modifications for gout","volume":"8","author":"Saag KG","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin M","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CEJ.0b013e328313631a","article-title":"A prospective study of gout and cancer","volume":"18","author":"Boffetta P","year":"2009","journal-title":"European Eur J Cancer Prev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jbspin.2011.09.011","article-title":"Increased risk of cancer among gout patients: a nationwide population study","volume":"79","author":"Kuo CF","year":"2012","journal-title":"Joint Bone Spine"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-028892","article-title":"Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study","volume":"9","author":"Chuang JP","year":"2019","journal-title":"BMJ Open"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","article-title":"Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant","volume":"12","author":"Kang DH","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames BN","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"807648","DOI":"10.3389\/fimmu.2021.807648","article-title":"Potential Role of the Gut Microbiome in Colorectal Cancer Progression","volume":"12","author":"Kim J","year":"2021","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00296-021-05007-x","article-title":"Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development","volume":"42","author":"M\u00e9ndez-Salazar EO","year":"2022","journal-title":"Rheumatol Int"},{"key":"ref35","article-title":"A Retrospective Review of Tumor Lysis Syndrome Associated With Colorectal Cancer","volume":"12","author":"Ansari Z","year":"2020","journal-title":"Cureus"},{"key":"ref36","article-title":"Hyperuricemia Associated with Thiazide Diuretics in Hypertensive Adults","volume":"11","author":"Raja R","year":"2019","journal-title":"Cureus"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Risco aumentado de c\u00e2ncer colorretal em pacientes com gota tof\u00e1cea cr\u00f4nica: um estudo populacional"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032023000300339&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:44:48Z","timestamp":1695642288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032023000300339&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["S0004-28032023000300339"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.230302023-43","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"type":"electronic","value":"1678-4219"},{"type":"print","value":"0004-2803"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}